Shohei Nishimon

Significance of Measurements of Peripheral Carbonyl Stress Markers in a Cross-sectional and Longitudinal Study in Patients With Acute-stage Schizophrenia

Narimasa Katsuta, Tohru Ohnuma, Hitoshi Maeshima et al. · Schizophrenia Bulletin · 2014 · 39 citations · Full text

Carbonyl Stress, Psychiatry, Carbonyl Stress Markers +13

Altered serum glyceraldehyde-derived advanced glycation end product (AGE) and soluble AGE receptor levels indicate carbonyl stress in patients with schizophrenia

Mayu Takeda, Tohru Ohnuma, Masayoshi Takeuchi et al. · Neuroscience Letters · 2015 · 23 citations · Full text

Tasimelteon for treating non-24-h sleep-wake rhythm disorder

Shohei Nishimon, Mari Nishimon, Seiji Nishino · Expert Opinion on Pharmacotherapy · 2019 · 21 citations

High serum soluble tumor necrosis factor receptor 1 predicts poor treatment response in acute-stage schizophrenia

Shohei Nishimon, Tohru Ohnuma, Yuto Takebayashi et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2017 · 15 citations

Psychiatry, Psychotic Disorder, Psychiatric Genetics +4

Intraperitoneal injection of ginkgolide B, a major active compound of Ginkgo biloba, dose-dependently increases the amount of wake and decreases non-rapid eye movement sleep in C57BL/6 mice

Shohei Nishimon, Mai Yamaguchi, Hisae Muraki et al. · Neuroscience Letters · 2020 · 14 citations

Sleep, Ginkgolide B, Ophthalmology +6